Finally, due to its ability to decrease RBP4 serum levels and, consequentially, to modulate insulin resistance and glucose intolerance, fenretinide could have a positive impact on neurological diseases in which glucose metabolic dysfunctions represent a risk factor [67]. The gene discussed is RBP4; the disease is Insulin resistance.